Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?

BACKGROUND The influence of neuroinflammation on neuronal function and hippocampal atrophy in Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) is still unclear. OBJECTIVES Here we investigated whether microglial activation measured by [11C]PK11195 PET is associated with neuronal function measured by cerebral glucose metabolic rate (rCMRGlc) using FDG-PET and hippocampal volume measurements. METHODS We enrolled 25 subjects (9 PDD, 8 AD, and 8 controls) who underwent PET scans with [11C](R)PK11195, [18F]FDG, and volumetric MRI scanning. RESULTS SPM correlation analysis in AD and PDD showed a negative correlation between hippocampal volume and microglial activation within hippocampus or parahippocampus and with cortical and subcortical areas of projections from hippocampus, while there was a positive correlation between rCMRGlc in cortical and subcortical areas of projections from hippocampus and hippocampal volume. Hippocampal volume was significantly reduced in AD compared to controls but not in PDD. CONCLUSIONS These findings indicate that microglial activation inversely correlated with hippocampal volume and hippocampal rCMRGlc in neurodegenerative diseases with dementia, providing further evidence for the central role of microglial activation in neurodegenerative diseases.

[1]  Gennaro Pagano,et al.  Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature. , 2014, Journal of Alzheimer's disease : JAD.

[2]  Masahiro Fujita,et al.  Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.

[3]  Alexander Gerhard,et al.  Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.

[4]  M. Heneka,et al.  Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice , 2011, Neuroscience.

[5]  Richard S. Frackowiak,et al.  Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease , 2013, PLoS Comput. Biol..

[6]  Richard Camicioli,et al.  Parkinson's disease is associated with hippocampal atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[7]  Amity E. Green,et al.  Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[8]  Alexander Hammers,et al.  A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 , 2007, NeuroImage.

[9]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[10]  K. Andreasson,et al.  Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease , 2013, Experimental Neurology.

[11]  Bin Liu,et al.  Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.

[12]  A. Kastrup,et al.  Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[13]  J. Koenigsknecht-Talboo,et al.  Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines , 2005, The Journal of Neuroscience.

[14]  Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis , 2014, Journal of Neuroinflammation.

[15]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[16]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[17]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[18]  Charles D. Smith,et al.  MRI Temporal Lobe Volume Measures and Neuropsychologic Function in Alzheimer's Disease , 1999, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[19]  Reyes García-Eulate,et al.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. , 2014, Brain : a journal of neurology.

[20]  Paul Edison,et al.  Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia , 2015, Alzheimer's & Dementia.

[21]  Sebastien Ourselin,et al.  Cerebral atrophy in mild cognitive impairment and Alzheimer disease , 2013, Neurology.

[22]  P. Filardi,et al.  β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? , 2013, Journal of Alzheimer's disease : JAD.

[23]  Francis J McMahon,et al.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. , 2013, Brain : a journal of neurology.

[24]  Christer Halldin,et al.  Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects , 2012, EJNMMI Research.

[25]  Paul Edison,et al.  Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. , 2015, Brain : a journal of neurology.

[26]  Alexander Gerhard,et al.  In vivo imaging of neuroinflammation , 2002, European Neuropsychopharmacology.

[27]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[29]  W. Le,et al.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases , 2015, Molecular Neurobiology.

[30]  M. O’Banion,et al.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed , 2014, Journal of Neuroinflammation.

[31]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Makoto Sawada,et al.  Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.

[33]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[34]  Ole Isacson,et al.  Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy , 2009, The Journal of Neuroscience.

[35]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[36]  Philippe Hantraye,et al.  Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.

[37]  Tetsuya Suhara,et al.  Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor , 2007, Brain Research.

[38]  Makoto Sawada,et al.  Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains , 2003, Acta Neuropathologica.

[39]  M. Tansey,et al.  Molecular Neurodegeneration BioMed Central Review , 2009 .

[40]  S. Cheon,et al.  Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles , 2011, Journal of clinical neurology.

[41]  D. Aarsland,et al.  A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  M. Emre.  Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[43]  R. Maccioni,et al.  Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches , 2014, Front. Cell. Neurosci..

[44]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[45]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[46]  Paul Edison,et al.  Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia , 2013, Neuropsychopharmacology.